# Dynamic Hydrogels in Breast Tumor Models

## TL;DR

This paper reviews how dynamic hydrogels can improve breast tumor models by mimicking the natural tissue environment and enhancing drug delivery.

## Contribution

The paper highlights the novel integration of nanoparticles with dynamic hydrogels for advanced breast cancer modeling and treatment.

## Key findings

- Dynamic hydrogels adapt to physiological cues, offering better tumor modeling than static hydrogels.
- Hydrogels with nanoparticles improve drug delivery and therapeutic efficacy in breast cancer treatment.
- Engineered hydrogels support tissue regeneration and localized drug release, minimizing side effects.

## Abstract

Fabricating breast tumor models that mimic the natural breast tissue-like microenvironment (normal or cancerous) both physically and bio-metabolically, despite extended research, is still a challenge. A native-mimicking breast tumor model is the demand since complex biophysiological mechanisms in the native breast tissue hinder deciphering the root causes of cancer initiation and progression. Hydrogels, which mimic the natural extracellular matrix (ECM), are increasingly demanded for various biomedical applications, including tissue engineering and tumor modeling. Their biomimetic 3D network structures have demonstrated significant potential to enhance the breast tumor model, treatment, and recovery. Additionally, 3D tumor organoids cultivated within hydrogels maintain the physical and genetic traits of native tumors, offering valuable platforms for personalized medicine and therapy response evaluation. Hydrogels are broadly classified into static and dynamic hydrogels. Static hydrogels, however, are inert to external stimuli and do not actively participate in biological processes or provide scaffolding systems. Dynamic hydrogels, on the other hand, adapt and respond to the surrounding microenvironment or even create new microenvironments according to physiological cues. Dynamic hydrogels typically involve reversible molecular interactions—through covalent or non-covalent bonds—enabling the fabrication of hydrogels tailored to meet the mechanical and physiological properties of target tissues. Although both static and dynamic hydrogels can be advanced by incorporating active nanomaterials, their combinations with dynamic hydrogels provide enhanced functionalities compared to static hydrogels. Further, engineered hydrogels with adipogenic and angiogenic properties support tissue integration and regeneration. Hydrogels also serve as efficient delivery systems for chemotherapeutic and immunotherapeutic agents, enabling localized, sustained release at tumor sites. This approach enhances therapeutic efficacy while minimizing systemic side effects, supporting ongoing research into hydrogel-based breast cancer therapies and reconstructive solutions. This review summarizes the roles of dynamic hydrogels in breast tumor models. Furthermore, this paper discusses the advantages of integrating nanoparticles with dynamic hydrogels for drug delivery, cancer treatment, and other biomedical applications, alongside the challenges and future perspectives.